Ryvu Announces Partial Clinical Hold of Phase Ib Clinical Trial of RVU120 (SEL120) in Acute …,

KRAKOW, Poland, April 8, 2021 /PRNewswire/ — Ryvu Therapeutics (WSE:RVU), a clinical stage drug discovery and development company focusing …, KRAKOW, Poland, April 8, 2021 /PRNewswire/ — Ryvu Therapeutics (WSE:RVU), a clinical stage drug discovery and development company focusing …, Read More

Scroll to Top